Original Article

Smoking Cessation Success and Affecting Factors in Geriatric Patients

Abstract

Background: There are difficulties in the treatment of smoking cessation in elderly patients. However, elderly smokers who gave up smoking had lower rates of death from heart attack, stroke, and cancer, as well as improved cognitive function. This study aimed to investigate the affecting factors and the success of smoking cessation rate in patients aged 60 and over in Turkey.

Methods: Six smoking cessation outpatient clinics from four provinces were included in the study. The records of 1,065 patients who applied to a smoking cessation outpatient clinic between 2016 and 2019 and who were 60 yr of age or older were scanned. Overall, 917 cases that could be reached after treatment were included in the study. Smoking cessation rates at the first month, 3rd month, 6th month, 9th month and 12th month were given.

Results: Of the 917 cases, 65.1% were male and 34.9% were female. Smoking cessation rates were 45.6% on the first month, 39% on the third month, 35.1% on the sixth month, 31.2% on the ninth month, and 30.3% at the twelfth month. Smoking cessation success was higher in men than in women.

Conclusion: Since the success of smoking cessation in the elderly was similar to that of adults. Since smoking is an independent risk factor for death in the elderly, there should be greater willingness to provide elderly patients with smoking cessation treatment to reduce physical function loss and promote healthier aging.

 

1. TUIK 2021 https://data.tuik.gov.tr/Bulten/Index?p=Istatistiklerle-Yaslilar-2021-45636#:~:text=T%C3%BCrkiye'de%202021%20y%C4%B1l%C4%B1nda%20toplam,bir%20ya%C5%9Fl%C4%B1%20fert%20ya%C5%9Fad%C4%B1%C4%9F%C4%B1%20g%C3%B6r%C3%BCld%C3%BC.
2. Centers for Disease Control and Prevention and The Merck Company Foundation. The state of aging and health in America 2007 [Internet]. The Merck Company Foundation, Whitehouse Station, NJ; 2007. http://www.cdc.gov/aging/pdf/saha_2007.pdf.
3. United Nations. World Population Ageing [Internet]. United States: United Nations, Department of Economic and Social Affairs, Population Division. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf (Accessed on August 25, 2015).
4. Müezzinler A, Mons U, Gellert C, Schöttker B, Jansen E, Kee F, O’Doherty MG, Kuulasmaa K, Freedman ND, Abnet CC, Wolk A. Smoking and all-cause mortality in older adults: Results from the CHANCES consortium. Am. J. Prev. Med. 2015 Nov;49(5):e53–63.
5. Appel DW, Aldrich TK. Smoking cessation in the elderly. Clin. Geriatr. Med. 2003 Feb;19(1):77-100.
6. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991 Jun 6;324(23):1619-25.
7. Centers for Disease Control. Health benefits of smoking cessation: A report of the Surgeon General [Internet]. Centers for Disease Control: Office on Smoking and Health; 1990.
8. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. Br Med J. 1979 Jul;2(6184):231-5.
9. Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012 Jun;172(11):837-44.
10. Doolan DM, Froelicher ES. Smoking cessation interventions and older adults. Prog Cardiovasc Dis. 2008 Aug;23(3):119-27.
11. Timmermans EJ, Huisman M, Kok AA, Kunst AE. Smoking cessation and 16-year trajectories of functional limitations among Dutch older adults: Results from the Longitudinal Aging Study Amsterdam. J. Gerontol: Series A. 2018 Nov;73(12):1722-8.
12. Maguire CP, Ryan J, Kelly A, O'Neill DE, Coakley D, Walsh JB. Do patient age and medical condition influence medical advice to stop smoking?. Age and Ageing. 2000 May;29(3):264-6.
13. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J. Behav. Med. 1989 Apr;12(2):159-82.
14. Scholz J, Santos PC, Buzo CG, Lopes NH, Abe TM, Gaya PV, et al. Effects of aging on the effectiveness of smoking cessation medication. Oncotarget. 2016 May;7(21):30032.
15. Burstein AH, Fullerton T, Clark DJ, Faessel HM. Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers. J. Clin. Pharmacol. 2006 Nov;46(11):1234-40.
16. Gunay T, Pekel O, Simsek H, Sahan C, Soysal A, Kilinc O, et al. Smoking habits and cessation success. Saudi Med J. 2014;35(6):585-91.
17. Çelik İ, Yüce D, Hayran M, Erman M, Kılıçkap S, Buzgan T, et al. Nationwide smoking cessation treatment support program–Turkey project. Health Policy. 2015 Jan;119(1):50-6.
18. Chang CP, Huang WH, You CH, Hwang LC, Lu IJ, Chan HL. Factors correlated with smoking cessation success in older adults: a retrospective cohort study in Taiwan. IJERPH. 2019 Sep;16(18):3462.
19. Potter V. Smoking cessation and the older patient [Internet]. 2011 Mar. https://www.gmjournal.co.uk/media/21751/march200p127.pdf
20. Yüce GD, Duru S, Ulaşlı SS, Ardıç S. Sıgara Bırakma Tedavısının 65 Yaş Ve Üzerı Hastalardakı Etkınlığı. Turkish Journal of Geriatrics/Türk Geriatri Dergisi. 2013 Jul;16(3)
21. Abdullah AS, Lam TH, Chan SK, Leung GM, Chi I, Ho WW, et al. Effectiveness of a mobile smoking cessation service in reaching elderly smokers and predictors of quitting. BMC geriatrics. 2008 Dec;8(1):1-9.
Files
IssueVol 52 No 12 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v52i12.14319
Keywords
Smoking Cessation Geriatrics Smoking cessation rates Side effects
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Duru Çetinkaya P, Turan A, Deniz PP, Çetinkaya F, Arpaz S, Uysal A, Dülger S, Salepçi B, Kilinç O, Görek Dilektaşlı A. Smoking Cessation Success and Affecting Factors in Geriatric Patients. Iran J Public Health. 2023;52(12):2583-2589.